Table 2.
Descriptive characteristics | Patients treated with oral blood glucose lowering drugs | Monotherapy | Fixed combination | Dual therapy |
---|---|---|---|---|
No of patients with diabetes* | 169,375 | 91,816 | 31,674 | 19,573 |
54.2% | 18.7% | 11.6% | ||
Prevalence | 4.2% | 2.3% | 0.8% | 0.5% |
Female | 3.9% | 2.2% | 0.7% | 0.4% |
Male | 4.5% | 2.4% | 0.8% | 0.5% |
Average age | 68.9 | 68.3 | 71.9 | 67.5 |
% of females | 49.1% | 49.8% | 49.4% | 47.0% |
Mean no of prescribed packs/year | 72.5 | 66.6 | 71.2 | 86.8 |
For oral blood glucose lowering drugs | 17.7 | 13.1 | 16.4 | 31.4 |
For insulin | 1.0 | 1.0 | 1.0 | 1.0 |
For other drugs | 54.8 | 53.6 | 54.7 | 55.5 |
DDD 1000 persons/day | 175.6 | 85.2 | 32.2 | 26.1 |
For oral blood glucose lowering drugs | 40.8 | 14.6 | 7.3 | 9.6 |
For insulin | 3.9 | 2.2 | 0.7 | 0.5 |
For other drugs | 134.8 | 70.6 | 24.9 | 16.4 |
Mean no of hospitalization/year (per 1000 patients) | 328‰ | 328‰ | 314‰ | 298‰ |
Mean no of specialist examinations/year | 35.1 | 34.0 | 30.1 | 38.6 |
Notes:
The 169,375 patients include both the sum of patients in monotherapy, fixed combination and dual thearpy (∑ = 143,063), and patients in mixed therapy: (N = 26,312).
Abbreviation: DDD, defined daily dose.